COMPASS Pathways Net Income 2019-2024 | CMPS
COMPASS Pathways net income from 2019 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| COMPASS Pathways Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-155 |
| 2023 | $-118 |
| 2022 | $-92 |
| 2021 | $-72 |
| 2020 | $-60 |
| 2019 | $-20 |
| 2018 | $-13 |
| COMPASS Pathways Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-43 |
| 2024-09-30 | $-39 |
| 2024-06-30 | $-38 |
| 2024-03-31 | $-35 |
| 2023-12-31 | $-33 |
| 2023-09-30 | $-33 |
| 2023-06-30 | $-28 |
| 2023-03-31 | $-24 |
| 2022-12-31 | $-31 |
| 2022-09-30 | $-18 |
| 2022-06-30 | $-21 |
| 2022-03-31 | $-21 |
| 2021-12-31 | $-26 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-18 |
| 2021-03-31 | $-13 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-17 |
| 2020-06-30 | |
| 2020-03-31 | $-9 |
| 2019-12-31 | |
| 2019-09-30 | $-6 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.358B | $0.000B |
| COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.417B | 25.21 |
| Elevance Health (ELV) | United States | $84.565B | 10.91 |
| CVS Health (CVS) | United States | $75.952B | 9.44 |
| Cencora (COR) | United States | $54.132B | 18.82 |
| DiDi Global (DIDIY) | China | $21.231B | 32.22 |
| Natera (NTRA) | United States | $20.665B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.308B | 13.03 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Doximity (DOCS) | United States | $11.108B | 57.77 |
| CochLear (CHEOY) | Australia | $11.097B | 0.00 |
| Revvity (RVTY) | United States | $10.729B | 18.46 |
| ICON (ICLR) | Ireland | $10.678B | 9.93 |
| Viatris (VTRS) | United States | $9.882B | 3.40 |
| Avantor (AVTR) | United States | $8.756B | 12.72 |
| HealthEquity (HQY) | United States | $8.482B | 41.73 |
| Medpace Holdings (MEDP) | United States | $8.385B | 22.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.090B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.825B | 13.37 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.093B | 37.89 |
| Bausch + Lomb (BLCO) | Canada | $4.082B | 24.06 |
| Sotera Health (SHC) | United States | $3.636B | 20.66 |
| Alignment Healthcare (ALHC) | United States | $2.950B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.918B | 37.95 |
| Concentras Parent (CON) | United States | $2.739B | 15.83 |
| Organon (OGN) | United States | $2.090B | 2.22 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| Premier (PINC) | United States | $2.056B | 14.07 |
| Progyny (PGNY) | United States | $1.874B | 41.24 |
| GeneDx Holdings (WGS) | United States | $1.696B | 65.33 |
| PACS (PACS) | United States | $1.666B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.638B | 30.50 |
| Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.219B | 9.27 |
| Agilon Health (AGL) | United States | $1.105B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.054B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.892B | 13.93 |
| Nutex Health (NUTX) | United States | $0.884B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
| QDM (QDMI) | Hong Kong, SAR China | $0.691B | 0.00 |
| Embecta (EMBC) | United States | $0.677B | 4.56 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Enhabit (EHAB) | United States | $0.536B | 44.08 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
| Sonida Senior Living (SNDA) | United States | $0.496B | 0.00 |
| LifeMD (LFMD) | United States | $0.434B | 0.00 |
| SBC Medicals (SBC) | United States | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.203B | 0.00 |
| Beauty Health (SKIN) | United States | $0.185B | 0.00 |
| Oncology Institute (TOI) | United States | $0.179B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| OncoCyte (OCX) | United States | $0.074B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| KindlyMD (KDLY) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.033B | 0.00 |
| Biodesix (BDSX) | United States | $0.032B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |